Clinical Trial Update: A Clinical Study of Mesenchymal Stem Cell Exosomes Nebulizer for the Treatment of ARDS [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating a nebulized mesenchymal stem cell exosome therapy for Acute Respiratory Distress Syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• Mesenchymal Stem Cell Exosome Nebulizer

Snippet

Sponsor: Ruijin Hospital | Conditions: Acute Respiratory Distress Syndrome | Phase 1, Phase 2 | Status: COMPLETED